Quadrant Capital Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-753
| Closed | -$3.34K | – | 2801 |
|
|
2024
Q4 | $3.34K | Sell |
753
-14
| -2% | -$57 | ﹤0.01% | 2400 |
|
|
2024
Q3 | $3.16K | Sell |
767
-1,259
| -62% | -$6.77K | ﹤0.01% | 2415 |
|
|
2024
Q2 | $13.2K | Sell |
2,026
-3,577
| -64% | -$25.3K | ﹤0.01% | 2021 |
|
|
2024
Q1 | $48.8K | Sell |
5,603
-2,975
| -35% | -$36.1K | ﹤0.01% | 1419 |
|
|
2023
Q4 | $98.1K | Buy |
8,578
+3,497
| +69% | +$34.6K | 0.01% | 1010 |
|
|
2023
Q3 | $48.9K | Sell |
5,081
-1,220
| -19% | -$12K | ﹤0.01% | 1282 |
|
|
2023
Q2 | $67K | Sell |
6,301
-396
| -6% | -$4.26K | 0.01% | 1103 |
|
|
2023
Q1 | $70.5K | Buy |
6,697
+3,795
| +131% | +$42.5K | 0.01% | 1034 |
|
|
2022
Q4 | $36K | Sell |
2,902
-866
| -23% | -$9.82K | ﹤0.01% | 1366 |
|
|
2022
Q3 | $39K | Buy |
3,768
+3,594
| +2,066% | +$40.7K | 0.01% | 1177 |
|
|
2022
Q2 | $2K | Buy |
174
+136
| +358% | +$1.6K | ﹤0.01% | 2229 |
|
|
2022
Q1 | $0 | Buy |
38
+16
| +73% | +$183 | ﹤0.01% | 2591 |
|
|
2021
Q4 | $0 | Sell |
22
-80
| -78% | -$982 | ﹤0.01% | 2602 |
|
|
2021
Q3 | $1K | Sell |
102
-29
| -22% | -$375 | ﹤0.01% | 2325 |
|
|
2021
Q2 | $2K | Sell |
131
-24
| -15% | -$275 | ﹤0.01% | 2109 |
|
|
2021
Q1 | $2K | Buy |
155
+80
| +107% | +$845 | ﹤0.01% | 2076 |
|
|
2020
Q4 | $1K | Buy |
+75
| New | +$821 | ﹤0.01% | 2132 |
|
|
2020
Q1 | – | Sell |
-558
| Closed | -$7K | – | 2183 |
|
|
2019
Q4 | $7K | Hold |
558
| – | – | ﹤0.01% | 2001 |
|
|
2019
Q3 | $4K | Hold |
558
| – | – | ﹤0.01% | 1965 |
|
|
2019
Q2 | $6K | Sell |
558
-108
| -16% | -$1.21K | ﹤0.01% | 1940 |
|
|
2019
Q1 | $7K | Hold |
666
| – | – | ﹤0.01% | 1780 |
|
|
2018
Q4 | $5K | Hold |
666
| – | – | ﹤0.01% | 1641 |
|
|
2018
Q3 | $10K | Hold |
666
| – | – | ﹤0.01% | 1290 |
|
|
2018
Q2 | $10K | Hold |
666
| – | – | ﹤0.01% | 1258 |
|
|
2018
Q1 | $8K | Hold |
666
| – | – | ﹤0.01% | 1354 |
|
|
2017
Q4 | $8K | Hold |
666
| – | – | ﹤0.01% | 1276 |
|
|
2017
Q3 | $8K | Hold |
666
| – | – | ﹤0.01% | 1271 |
|
|
2017
Q2 | $10K | Hold |
666
| – | – | ﹤0.01% | 1102 |
|
|
2017
Q1 | $9K | Hold |
666
| – | – | ﹤0.01% | 1115 |
|
|
2016
Q4 | $8K | Hold |
666
| – | – | ﹤0.01% | 1094 |
|
|
2016
Q3 | $8K | Hold |
666
| – | – | 0.01% | 1118 |
|
|
2016
Q2 | $7K | Hold |
666
| – | – | ﹤0.01% | 1121 |
|
|
2016
Q1 | $6K | Buy |
+666
| New | +$5.49K | ﹤0.01% | 1111 |
|
Other funds holding IRWD
SCM
AC
B
KCM
Quadrant Capital Group's IRWD Position: Q1 2025 in Review
Quadrant Capital Group sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 753 shares — an estimated $3.34K sold.
Quadrant Capital Group first reported a position in IRWD in Q1 2016 and held it in 33 quarters. The position peaked at $98.1K in Q4 2023. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.
- Quadrant Capital Group reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Quadrant Capital Group sold 753 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $3.34K.
- Quadrant Capital Group first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 33 quarters.
- Quadrant Capital Group's Ironwood Pharmaceuticals position peaked at $98.1K in Q4 2023.
- 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.
Based on Quadrant Capital Group's 13F filing for Q1 2025, filed 13 May 2025.